About Vartelus
Vartelus was imagined and designed by the founders to support patients to achieve better health outcomes and to revolutionise the way pharma engages with HCPs in a rapidly changing world.
Vartelus is a truly ‘Disruptive Innovation’ because it enables pharma to better engage with physicians to make sure they feel confident and competent in the medicines and medical devices they prescribe and know that patients will be better supported. This means fewer returning patients which creates better health outcomes and significant savings for healthcare systems worldwide.
Understanding the commercial applications of this technology and the positive impact it can have will become essential for the pharmaceutical industry, as will the significant contribution to increasing market share of the product portfolio.
Engagement with Vartelus takes ‘conversational interaction’ with technology to a different, unique, and innovative level. With high quality digital humans, research shows that people ‘trust’ a digital human more with sensitive information and questions than they do a human.
You may have seen the recent articles and news stories about ChatGPT and, Google’s Bard AI system, giving wrong information to questions asked. Other key influencers are leading with headlines such as "ChatGPT drives misinformation in healthcare," which is an essential warning of potential dangers and inaccuracies that may arise from the use of large AI language models in industries like ours.
Vartelus has been designed specifically for life science in that it is 100% compliant, delivers 100% consistent information, is aligned to brand strategy and does it all at infinite scale on-demand.
Management Team
